Clincosm LogoSign in Get a demo

SatisPreP: Sexual Health Impact of Using Pre-exposure HIV Prophylaxis

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05269199
Collaborator
(none)
50
Enrollment
7
Locations
6
Anticipated Duration (Months)
7.1
Patients Per Site
1.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Sexual Health Impact of Using Pre-exposure HIV Prophylaxis
    Anticipated Study Start Date :
    Apr 1, 2022
    Anticipated Primary Completion Date :
    Oct 1, 2022
    Anticipated Study Completion Date :
    Oct 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Sexual health satisfaction [1 day during the scheduled consultation]

      To study the sexual health satisfaction of men who have sex with men (MSM), since the use of HIV prophylaxis by pre-exposure treatment (PrEP), compared to the time before PrEP.

    Secondary Outcome Measures

    1. Sentimental satisfaction [1 day during the scheduled consultation]

      To study the sentimental satisfaction since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.

    2. Risky behaviours [1 day during the scheduled consultation]

      To study risky behaviours without, then on PrEP since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.

    3. Specific care [1 day during the scheduled consultation]

      Describe the use of specific care during PrEP.

    4. Predictors of satisfaction [1 day during the scheduled consultation]

      Define possible predictors of satisfaction with PrEP.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription.

    • Able to give his non-opposition to participate in the research.

    • Affiliation to a social security scheme.

    Exclusion Criteria:

    • Patient under curatorship/guardianship or safeguard of justice

    • Refusal to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CH Brioude Brioude France
    2 CEGIDD Clermont Ferrand Clermont-Ferrand France
    3 CHU Clermont-Ferrand Clermont-Ferrand France
    4 CH Le Puy en Velay Le Puy-en-Velay France
    5 CH Montluçon Montluçon France
    6 CH Moulins Moulins France
    7 CH Vichy Vichy France

    Sponsors and Collaborators

    • University Hospital, Clermont-Ferrand

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Clermont-Ferrand
    ClinicalTrials.gov Identifier:
    NCT05269199
    Other Study ID Numbers:
    • RNI 2021 JACOMET
    First Posted:
    Mar 7, 2022
    Last Update Posted:
    Mar 8, 2022
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Clermont-Ferrand
    PrEP
    MSM

    Study Results

    No Results Posted as of Mar 8, 2022